{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T05:35:05Z","timestamp":1786772105490,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,19]]},"DOI":"10.7759\/cureus.111138","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T10:53:06Z","timestamp":1781866386000},"source":"Crossref","is-referenced-by-count":1,"title":["Acute Pancreatitis Complicating L-asparaginase Therapy in Pediatric Oncology: A Case Report"],"prefix":"10.7759","author":[{"given":"Loubna","family":"Larda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Ryouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elouassifi","family":"Kawtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El Alaoui","family":"Mounia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noufissa","family":"Benajiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.87092","article-title":"Pediatric acute lymphoblastic leukemia: recent advances for a promising future","author":"Tandon S","year":"2019","unstructured":"Tandon S, Punnett AS. Pediatric acute lymphoblastic leukemia: recent advances for a promising future. Advances in Hematologic Malignancies. Abdul Hamid G (ed): IntechOpen, London; 2019. 31-56. 10.5772\/intechopen.87092"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.46989\/001c.90958","article-title":"Asparaginase-associated pancreatitis complicated by pancreatic fluid collection treated with endoscopic cistogastrostomy in pediatric acute lymphoblastic leukemia: a case report and systematic review of the literature","volume":"5","author":"Fiumana G","year":"2023","unstructured":"Fiumana G, Pancaldi A, Bertani H, Boarino V, Cellini M, Iughetti L. Asparaginase-associated pancreatitis complicated by pancreatic fluid collection treated with endoscopic cistogastrostomy in pediatric acute lymphoblastic leukemia: a case report and systematic review of the literature. Clin Hematol Int. 2023, 5:51-61. 10.46989\/001c.90958","journal-title":"Clin Hematol Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.278411","article-title":"Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy","volume":"107","author":"Karol SE","year":"2022","unstructured":"Karol SE, Pei D, Smith CA, et al.. Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy. Haematologica. 2022, 107:371-80. 10.3324\/haematol.2021.278411","journal-title":"Haematologica"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18745","article-title":"Impact of asparaginase discontinuation on outcomes of children with acute lymphoblastic leukaemia receiving the Japan Association of Childhood Leukaemia Study ALL-02 protocol","volume":"201","author":"Ishida H","year":"2023","unstructured":"Ishida H, Imamura T, Tatebe Y, et al.. Impact of asparaginase discontinuation on outcomes of children with acute lymphoblastic leukaemia receiving the Japan Association of Childhood Leukaemia Study ALL-02 protocol. Br J Haematol. 2023, 201:1200-8. 10.1111\/bjh.18745","journal-title":"Br J Haematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000001715","article-title":"Management of acute pancreatitis in the pediatric population: a clinical report from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Pancreas Committee","volume":"66","author":"Abu-El-Haija M","year":"2018","unstructured":"Abu-El-Haija M, Kumar S, Quiros JA, et al.. Management of acute pancreatitis in the pediatric population: a clinical report from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Pancreas Committee. J Pediatr Gastroenterol Nutr. 2018, 66:159-76. 10.1097\/MPG.0000000000001715","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5114\/pg.2017.70470","article-title":"Acute pancreatitis in children","volume":"13","author":"Grzybowska-Chlebowczyk U","year":"2018","unstructured":"Grzybowska-Chlebowczyk U, Jasielska M, Flak-Wancerz A, Wi\u0119cek S, Gruszczy\u0144ska K, Chlebowczyk W, Wo\u015b H. Acute pancreatitis in children. Prz Gastroenterol. 2018, 13:69-75. 10.5114\/pg.2017.70470","journal-title":"Prz Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30424-2","article-title":"Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study","volume":"18","author":"Wolthers BO","year":"2017","unstructured":"Wolthers BO, Frandsen TL, Baruchel A, et al.. Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study. Lancet Oncol. 2017, 18:1238-48. 10.1016\/S1470-2045(17)30424-2","journal-title":"Lancet Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30035-3","article-title":"Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus","volume":"17","author":"Schmiegelow K","year":"2016","unstructured":"Schmiegelow K, Attarbaschi A, Barzilai S, et al.. Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus. Lancet Oncol. 2016, 17:e231-9. 10.1016\/S1470-2045(16)30035-3","journal-title":"Lancet Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13568-023-01602-2","article-title":"Optimization and characterization of antileukemic L-asparaginase produced by Fusarium solani endophyte","volume":"13","author":"Osama S","year":"2023","unstructured":"Osama S, El-Sherei MM, Al-Mahdy DA, Bishr M, Salama O, Raafat MM. Optimization and characterization of antileukemic L-asparaginase produced by Fusarium solani endophyte. AMB Express. 2023, 13:96. 10.1186\/s13568-023-01602-2","journal-title":"AMB Express"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1070069","article-title":"Possible mechanism of metabolic and drug resistance with L-asparaginase therapy in childhood leukaemia","volume":"13","author":"Zhou R","year":"2023","unstructured":"Zhou R, Liang T, Li T, Huang J, Chen C. Possible mechanism of metabolic and drug resistance with L-asparaginase therapy in childhood leukaemia. Front Oncol. 2023, 13:1070069. 10.3389\/fonc.2023.1070069","journal-title":"Front Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.110034","article-title":"Acute pancreatitis in children with acute lymphoblastic leukemia using L-asparaginase: a review of the literature","author":"Zahra K","year":"2023","unstructured":"Zahra K, Cherif W, Fathallah N, et al.. Acute pancreatitis in children with acute lymphoblastic leukemia using L-asparaginase: a review of the literature. Pancreatic Cancer: Updates in Pathogenesis, Diagnosis and Therapies. Gad EH (ed): IntechOpen, London; 2023. 1-15. 10.5772\/intechopen.110034"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.3868.3868","article-title":"Risk factors for acute pancreatitis in patients with acute lymphoblastic leukemia","volume":"122","author":"Liu C","year":"2013","unstructured":"Liu C, Pei D, Devidas M, et al.. Risk factors for acute pancreatitis in patients with acute lymphoblastic leukemia. Blood. 2013, 122:3868. 10.1182\/blood.V122.21.3868.3868","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02208","article-title":"Asparaginase-associated pancreatitis in acute lymphoblastic leukemia: results from the NOPHO ALL2008 treatment of patients 1-45 years of age","volume":"38","author":"Rank CU","year":"2020","unstructured":"Rank CU, Wolthers BO, Grell K, et al.. Asparaginase-associated pancreatitis in acute lymphoblastic leukemia: results from the NOPHO ALL2008 treatment of patients 1-45 years of age. J Clin Oncol. 2020, 38:145-54. 10.1200\/JCO.19.02208","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22076","article-title":"Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis","volume":"53","author":"Kearney SL","year":"2009","unstructured":"Kearney SL, Dahlberg SE, Levy DE, Voss SD, Sallan SE, Silverman LB. Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis. Pediatr Blood Cancer. 2009, 53:162-7. 10.1002\/pbc.22076","journal-title":"Pediatr Blood Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.199356","article-title":"Trypsin-encoding PRSS1-PRSS2 variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group report","volume":"104","author":"Wolthers BO","year":"2019","unstructured":"Wolthers BO, Frandsen TL, Patel CJ, et al.. Trypsin-encoding PRSS1-PRSS2 variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group report. Haematologica. 2019, 104:556-63. 10.3324\/haematol.2018.199356","journal-title":"Haematologica"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3109\/08880019809018315","article-title":"L-asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia","volume":"15","author":"Sahu S","year":"1998","unstructured":"Sahu S, Saika S, Pai SK, Advani SH. L-asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1998, 15:533-8. 10.3109\/08880019809018315","journal-title":"Pediatr Hematol Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-025-06333-4","article-title":"Retrospective analysis of asparaginase-associated pancreatitis in pediatric acute lymphoblastic leukemia: focus on rechallenge with pegaspargase","volume":"151","author":"Jia C","year":"2025","unstructured":"Jia C, Li Q, Zhai X, Quan M, Bai B, Ding X. Retrospective analysis of asparaginase-associated pancreatitis in pediatric acute lymphoblastic leukemia: focus on rechallenge with pegaspargase. J Cancer Res Clin Oncol. 2025, 151:272. 10.1007\/s00432-025-06333-4","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.902117","article-title":"Current use of asparaginase in acute lymphoblastic leukemia\/lymphoblastic lymphoma","volume":"10","author":"Maese L","year":"2022","unstructured":"Maese L, Rau RE. Current use of asparaginase in acute lymphoblastic leukemia\/lymphoblastic lymphoma. Front Pediatr. 2022, 10:902117. 10.3389\/fped.2022.902117","journal-title":"Front Pediatr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.lrr.2022.100357","article-title":"Acute pancreatitis following L-asparaginase in acute lymphoblastic leukemia","volume":"18","author":"M'harzi S","year":"2022","unstructured":"M'harzi S, Elouali A, Lahrache K, Ghanam A, Babakhouya A, Rkain M, Benajiba N. Acute pancreatitis following L-asparaginase in acute lymphoblastic leukemia. Leuk Res Rep. 2022, 18:100357. 10.1016\/j.lrr.2022.100357","journal-title":"Leuk Res Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07461-5","article-title":"National Italian Delphi panel consensus: which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia?","volume":"20","author":"Lussana F","year":"2020","unstructured":"Lussana F, Minetto P, Ferrara F, Chiaretti S, Specchia G, Bassan R. National Italian Delphi panel consensus: which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia?. BMC Cancer. 2020, 20:956. 10.1186\/s12885-020-07461-5","journal-title":"BMC Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/490364-acute-pancreatitis-complicating-l-asparaginase-therapy-in-pediatric-oncology-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T10:53:07Z","timestamp":1781866387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/490364-acute-pancreatitis-complicating-l-asparaginase-therapy-in-pediatric-oncology-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.111138","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,19]]}}}